Actively Recruiting

Phase Not Applicable
Age: 18Years - 80Years
All Genders
NCT07427758

Effect of Cognitive Behavioral Therapy on Kinesiophobia and Functional Outcomes After Total Hip Arthroplasty.

Led by Cairo University · Updated on 2026-02-23

100

Participants Needed

1

Research Sites

30 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this clinical trial study is to evaluate the effectiveness of cognitive behavioral therapy in reducing kinesiophobia and improving Clinical outcomes in postoperative patients following total hip arthroplasty The main question it aims to answer is: Does the addition of cognitive behavioral therapy to standard physical therapy rehabilitation exercise reduce kinesiophobia and pain while improving functional mobility and quality of life in postoperative patients after total hip arthroplasty ? Participants will be divided into two groups to be compared: the first group (Control group) will only receive standard physical therapy rehabilitation exercises , consistent with routine post-total hip arthroplasty care, while the second group ( experimental group) will receive the same program in addition to cognitive behavioral therapy.

CONDITIONS

Official Title

Effect of Cognitive Behavioral Therapy on Kinesiophobia and Functional Outcomes After Total Hip Arthroplasty.

Who Can Participate

Age: 18Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Postoperative unilateral total hip arthroplasty for the first time
  • At least primary education
  • Age 18 years or older
  • Voluntary participation and willingness to closely follow the care plan
  • Agreement to continue the intervention and attend the six-month follow-up after discharge
  • High level of kinesiophobia on the Tampa Scale of Kinesiophobia
  • Medically stable and cleared by an orthopedic surgeon
Not Eligible

You will not qualify if you...

  • Revision surgery
  • Severe osteoarthritis in the opposite hip
  • Severe acute metabolic, neuromuscular, or cardiovascular disease
  • Body mass index above 40
  • Presence of cancer or any other orthopedic or neurological problem affecting treatment or assessments
  • Any condition interfering with communication
  • Lack of cooperation during the study
  • Cognitive disorder
  • Psychological disease or disorder
  • Previous participation in a cognitive behavioral therapy intervention
  • Pregnancy

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Cairo University Hospitals

Giza, Giza Governorate, Egypt, 2356

Actively Recruiting

Loading map...

Research Team

A

Ahmad El Melhat, Phd

CONTACT

S

Sara Ahmad Manasfi, BSc

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here